February 16, 2026 Status Conference Last Week At the February 10, 2026, status conference, the Court and counsel addressed several key administrative and case management issues in the MDL
The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)
Farxiga primarily removes glucose through the kidneys, while Ozempic slows gastric emptying and enhances insulin secretion
Gently swirl the vial until all powder dissolves completely
Most contain other ingredients (amino acids, herbal blends) that have nothing to do with the GHRH pathway
Cannot redeclare control with same name "grid_1_qv_desc_typography_font_family"